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Received January 3, 2011; accepted May 27, 2011AbstractBackground: Cytokines are involved in liver injury and cirrhosis and systemic and hepatic cytokine levels may help predict cirrhosis evolution.
However, the relevant survey has not been performed.
Methods: Male Sprague-Dawley rats (240e270 g) received either common bile duct ligation (BDL, animal model of cholestatic liver injury) or
sham operation (control). Five rats were sacrificed and liver and serum were collected from each in weeks 1, 2, 4, 6, 8 and 10 after surgery.
Hepatic expression of interferon-g (IFN-g), tumor necrosis factor-a (TNF-a), interleukin-10 (IL-10) and transforming growth factor-b (TGF-b)
were analyzed by immunohistochemial staining. The corresponding serum levels were measured by ELISA.
Results: Compared to the corresponding sham groups, hepatic expression of these cytokines in BDL rats was significantly and progressively
enhanced during cirrhosis development. However, serum IFN-g levels of BDL rats did not change significantly. Serum TNF-a of BDL rats
increased gradually and reached a peak in week 6. Serum TGF-b level was elevated up to week 8, whereas IL-10 level decreased progressively
until week 6.
Conclusion: Cirrhosis development in BDL rats is associated with progressively enhanced expression of hepatic pro-inflammatory and anti-
inflammatory cytokines, which is not in accord with the corresponding serum concentration. The circulating cytokine concentration may not
totally reflect the hepatic expression level throughout the development of cirrhosis.
Copyright  2011 Elsevier Taiwan LLC and the Chinese Medical Association. All rights reserved.
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Cytokines are soluble, hormone-like mediators synthesized
by a variety of cells in response to various stimuli, including
inflammation and tissue injury.1 The liver is a major organ in
the production as well as the elimination of cytokines and all
cell types in the liver are capable of producing cytokines.1
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doi:10.1016/j.jcma.2011.08.002has been investigated.1e4 Upon liver injury, the activated
Kupffer cells and T cells secret cytokines and soluble factors
that activate hepatic stellate cells (HSC). One of the key
cytokines involved in the activation of HSC is transforming
growth factor-b (TGF-b).5 Furthermore, tumor necrosis factor-
a (TNF-a) participates in HSC extracellular matrix protein
synthesis.6 Other pro-inflammatory cytokines e.g., interferon-
g (IFN-g) and anti-inflammatory cytokines e.g., interleukin-10
(IL-10) have also been implicated in the process of fibrosis and
cirrhosis.7,8
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However, there has been no systematic approach to evaluate
the whole picture of hepatic and circulating cytokine changes
throughout the formation of cirrhosis: cytokine levels in acute
liver damage induced by BDL when cirrhosis had not been
established has been reported.12,13 Some surveyed the serum
and hepatic cytokine changes in late cirrhosis.10 Since the
serial changes of cytokine production may contribute to
a better understanding and prediction of cirrhosis progression,
we investigated the kinetics of hepatic and serum cytokine
expression during the course of cirrhosis development induced
by BDL in rats.
2. Methods2.1. Animal modelMale Sprague-Dawley rats weighing 240e270 g at the time
of surgery were used in this study. Rats were housed in plastic
cages with free access to food and water. All rats were fasted
for 12 h before the operation. Secondary biliary cirrhosis was
induced by BDL.14 Under ketamine anesthesia (100 mg/kg,
intramuscularly), the common bile duct was exposed through
a midline abdominal incision. The common bile duct was
dissected and doubly ligated with 3-0 silk. The first ligature
was made below the junction of the hepatic ducts and the
second was made above the entrance of the pancreatic duct.
The incision was then closed and the animal allowed to
recover. A high yield of secondary biliary cirrhosis was noted
four weeks after the ligation.14,15 To avoid coagulation defects,
BDL rats received a weekly injection of vitamin K (50 mg/kg
intramuscularly). The control group (sham group) was
prepared by a technique similar to that described above for the
BDL group, except the common bile duct was not ligated. This
study was approved by the Taipei Veterans General Hospital
Animal Committee. The principles of laboratory animal care
were followed as described in the Guide for the Care and Use
of Laboratory Animals (DHEW publication no. [NIH] 85-23,
rev. 985, Office of Science and Health Reports, DRR/NIH,
Bethesda, MD 20205, USA).2.2. Immunohistochemical (IHC) stainingFrozen sections (5 mm thick) were fixed in acetone for
10 min and then treated with H2O2 to block endogenous
peroxidase activity. After normal serum blocking, the sections
were incubated with primary antibodies, then secondary
antibodies and then peroxidase anti-peroxidase complex with
intensive washing with phosphate-buffered saline between
steps. A positive stain was seen as the deposition of a stain
color by the diaminobenzidine substrate solution in the pres-
ence of the peroxidase. The sections were then counterstained
with Mayer’s hematoxylin, dehydrated and mounted. The final
results were observed under a visible light microscope.
The degree of color development in the stained section
treated with a negative control primary antibody, such asNS-1, normal goat serum or normal rabbit serum was defined
as grade 0. The degree of color development after treatment
with the positive control b-actin antibody was defined as grade
5. The intensity and percentage of staining of IFN-g, TNF-a,
TGF-b, and IL-10 were graded (with some modification) as
follows: significantly strong positive (5þ), dark brown stain-
ing in more than 75% of cells completely obscuring cytoplasm
and nucleus; strong positive (4þ), lower degree of brown
staining in > 75% of cells; intermediate strong positive (3þ),
brown staining in 50e75% of cells; intermediate weak posi-
tive (2þ), brown staining in 25e50% of cells; weak positive
(1þ), brown staining in < 25% of cells; absent (0), no
appreciable staining.162.3. Serum cytokinesThe concentration of cytokines in serum samples was
determined by enzyme-linked immunosorbent assay (ELISA)
following the manufacturer’s instructions for using kits
selective for rat IFN-g and TNF-a (American Research
Product Inc., Belmont, MA 02478 USA) as well as TGF-b and
IL-10 (R&D Systems Co., Minneapolis, MN, USA). Briefly,
serum samples from rats were incubated in immunoassay
plates coated with anti rat IFN-g, anti rat TNF-a, anti rat IL-10
or anti rat TGF-b. After washing, the plates were interacted
with polyclonal antibodies against rat IFN-g, anti TNF-a, anti
IL-10 or anti TGF-b, respectively, followed by addition of
secondary antibodyealkaline phosphatase conjugates and the
chromagen p-nitrophenyl phosphate. The concentration of
each cytokine in each serum sample was calculated from
a calibration curve constructed with cytokine standards.2.4. Determination of liver biochemistry parametersBlood was collected from the inferior vena cava into
a pyrogen-free syringe containing 75 U of heparin sodium.
Plasma was separated by centrifugation (3000 rpm for 10 min)
at 4 C with and then stored at e70 C in Eppendorf tubes.
The serum level of alanine aminotransferase (ALT), aspartate
aminotransferase (AST), alkaline phosphatase (Alk-P), albumin
and total bilirubin was evaluated with a Vitro DT chemistry
system (Johnson & Johnson Inc., New York, NY, USA).2.5. Statistical analysisThe data were assessed using the Friedman test for six
related samples and post hoc analysis with Wilcoxon signed-
rank tests if needed for comparison among BDL or sham-
operated rats at different time intervals after surgery. The
ManneWhitney U test for two independent samples was used
to analyze the differences between BDL and the corresponding
sham-operated groups. Linear trends were determined by
polynomial contrasts. The statistically significant difference
was set at p 0.05 and the results are shown as mean SD.
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of BDL ratsThe mortality rates of BDL rats at weeks 6, 8 and 10 were
100%, 94.12% and 100%, respectively.
Fig. 1 shows the histological findings for BDL rats at the
6 weeks post surgery. In the liver from BDL rats at 6 and
8 weeks post surgery, areas of remaining liver cells were
surrounded by bile duct proliferation and fibrotic tissue. The
intrahepatic architecture was interrupted by fibrotic bands
connecting the portal tracts and the original lobules were
replaced by pseudo-lobules of unusual shapes and variable
size.
In BDL rats 10 weeks post surgery, bile-duct proliferation
was extensive and some bile ducts appeared to be distorted and
distended. Most of the necrotic tissue had been replaced by
proliferating bile ducts. It was thus difficult to identify portal
tracts and many hepatocytes had disappeared.3.2. Serum cytokine concentrationsThe circulating cytokine levels in BDL rats and time-
matched, sham-operated groups are shown in Table 1.3.3. Serum cytokine concentrations and hepatic
expression of IFN-gThere was no significant change of serum IFN-g concen-
tration in either sham-operated or BDL groups throughout the
experimental course (Fig. 2A).
The circulating IFN-g levels were significantly higher in
BDL rats in week 6 ( p< 0.01) as compared with the time-
matched, sham-operated rats. Immunohistochemical staining
of liver tissue showed that IFN-g production was hardly
detectable in the sham-operated group whereas it was up-
regulated gradually in the BDL group from weeks 1 to 8
and was declined slightly lowered in week 10 (Fig. 2B). As
compared to the sham-operated group, the degree of IFN-g
IHC staining was elevated significantly from weeks 1 to 10
(sham-operated vs. BDL, p < 0.05 in week 1, <0.01 in week
2, <0.01 in week 4, <0.01 in week 6, <0.05 in week 8, andFig. 1. The histological change of livers from rats after BDL for 6, 8 and 10 weeks
have been replaced by regenerating bile ducts and fibrotic bands.<0.01 in week 10, respectively). The representative IHC
staining pattern (magnification 100) of livers from BDL and
sham-operated rats are shown below.3.4. Serum cytokine concentrations and hepatic
expression of TNF-aThe serum level of TNF-a in the BDL group increased
gradually, reached a peak in week 6 and then decreased to the
basal level in the later stages, but was not significantly
different from those of weeks 1, 2, 4, 8 or 10 (Fig. 3A).
Moreover, they were not significantly higher than those of the
corresponding sham-operated groups.
Hepatic production of TNF-a, as reflected by the degree of
IHC staining in BDL rats, increased gradually and the peak
level was noted in week 8 (Fig. 3B). Compared to the sham-
operated rats, the degree of IFN-g IHC staining was
elevated significantly in weeks 1 to 10 (BDL versus sham-
operated: p< 0.05 in week 1, <0.01 in week 2, <0.01 in
week 4, <0.05 in week 6, <0.01 in week 8, and <0.01 in week
10). The representative IHC staining pattern (magnification
100) of livers from BDL and sham-operated rats are shown
below.3.5. Serum cytokine concentrations and hepatic
expression of TGF-bSerum TGF-b in the BDL group increased gradually,
reached a peak in week 8 and then decreased slightly in week
10. Fig. 4A shows that compared to the sham-operated group,
a significant difference was reached in weeks 6 ( p< 0.01) and
8 ( p< 0.01).
Hepatic expression of TGF-b in the BDL group was up-
regulated gradually, reached a peak in week 6 then declined
slightly in weeks 8 to 10, whereas it was almost undetect-
able in the liver in the sham-operated group (Fig. 4). The
degree of IHC staining was significantly higher in the BDL
group compared to the sham-operated group in week 1
( p< 0.05), week 2 (p < 0.01), week 4 (p < 0.01), week 6
(p < 0.05), week 8 (p < 0.01), and week 10 (p < 0.01),
respectively. The representative IHC staining pattern
(magnification 100) of livers from BDL and sham-operated
rats is shown below., respectively (H & E staining; magnification 100). Most of the hepatocytes
Table 1
Serum concentration of cytokines in BDL and time-matched, sham-operated rats
IFN-g (ng/ml) TNF-a (pg/ml) TGF-b (ng/ml) IL-10 (pg/ml)
Shameoperated
Week 1 17.2 7.8 (18.7) 24.5 13.8 (19.0) 42.1 9.2 (37.0) 25.3 1.0 (25.4)
Week 2 19.0 14.2 (11.7) 21.7 10.2 (17.7) 51.2 26.3 (57.1) 25.9 1.8 (26.3)
Week 4 20.0 12.1 (19.9) 47.4 20.5 (46.6) 42.3 22.9 (36.3) 24.2 2.0 (24.1)
Week 6 8.2 4.0 (8.4) 44.2 23.9 (43.7) 24.1 5.3 (25.9) 22.9 2.2 (23.1)
Week 8 8.9 2.0 (8.8) 18.4 5.3 (19.6) 38.4 12.0 (33.1) 26.1 2.3 (26.2)
Week 10 7.6 1.9 (8.4) 15.7 2.6 (15.9) 33.9 8.4 (29.6) 25.1 1.3 (24.8)
BDL
Week 1 58.1 74.1 (29.4) 20.9 5.1 (19.2) 49.6 12.2 (50.3) 25.4 2.4 (24.4)
Week 2 28.8 17.6 (29.5) 16.4 3.8 (15.1) 60.0 16.8 (59.2) 24.9 2.1 (25.0)
Week 4 52.9 30.2 (52.7) 39.5 17.4 (28.9) 59.5 26.4 (54.2) 22.1 2.1 (22.1)
Week 6 33.3 32.6 (19.6)* 79.4 16.3 (83.6) 84.2 47.2 (58.5)* 19.6 3.3 (18.3)
Week 8 34.1 40.9 (18.2)* 20.2 6.3 (20.1) 168.2 60.5 (161.1)* 25.0 1.5 (24.4)
Week 10 18.5 13.6 (24.0) 29.1 16.9 (28.0) 149.9 123.3 (118.0)* 27.3 3.0 (27.5)
The data are expressed as mean SD (median). Statistically significant difference (*p< 0.05) between BDL and time-matched, sham-operated rats.
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expression of IL-10Serum level of IL-10 in BDL rats decreased gradually from
weeks 1 to 6 and increased gradually thereafter (Fig. 5A).Fig. 2. Kinetics of IFN-g expression in serum and liver tissue at 1, 2, 4, 6, 8 and 10 w
for each group). (B) Representative IHC staining patterns at different time pointsThere was no significant difference between the BDL and
sham-operated groups.
In BDL rats, the hepatic IHC staining degree of IL-10
increased gradually from weeks 1 to 4 then declined and
was significantly higher than that of the correspondingeeks after sham and BDL surgery. The data are expressed as mean SE (n¼ 5
are shown. Magnification 100.
Fig. 3. (A) Kinetics of TNF-a expression in serum and liver tissue at 1, 2, 4, 6, 8 and 10 weeks after sham and BDL surgery. The data are expressed as mean SE
(n¼ 5 for each group). (B) Representative IHC staining patterns at different time points are shown. Magnification 100.
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week 4 ( p< 0.01), week 6 ( p< 0.01) and week 8 ( p< 0.01),
while it was barely detected in the sham-operated group
(Fig. 5B). The representative IHC staining pattern (magnifi-
cation 100) of livers from BDL and sham rats is shown
below.3.7. b-ActinThe expression of b-actin was constant and stable in liver
tissue of both the BDL and the sham-operated groups from
weeks 1 to 10 (data not shown).3.8. Correlation between hepatic expression and serum
level of cytokinesWhen combining the sham-operated rats and BDL rats, the
hepatic IHC staining degree of TGF-b was positively corre-
lated with the serum level of TGF-b (r¼ 0.416, p< 0.05),
whereas the hepatic IL-10 expression level was negatively
correlated with its corresponding serum concentration(r¼e0.485, p< 0.05). There was no significant relationship
between hepatic and serum levels of IFN-g and TNF-a
(Fig. 6).3.9. Biochemical testsAs compared to the sham-operated group, plasma levels of
alanine aminotransferase (ALT), aspartate aminotransferase
(AST), alkaline phosphatase (ALK-P) and total bilirubin of the
BDL group were significantly higher throughout the experi-
ment and the albumin concentration was significantly lower
after week 4 (Fig. 7).
4. Discussion
Common bile duct ligation (BDL) is a well established
animal model used to induce cholestatic liver injury with
inflammation, fibrosis and cirrhosis.15 Histological examina-
tion has shown that hepatic lobular areas were gradually
replaced by proliferated bile ducts and fibrous tissue, which
led to typical biliary cirrhosis in four to eight weeks after
Fig. 4. (A) Kinetics of TGF-b expression in serum and liver tissue at 1, 2, 4, 6, 8 and 10 weeks after sham and BDL surgery. The data are expressed as mean SE
(n¼ 5 for each group). (B) Representative IHC staining patterns at different time points are shown. Magnification 100.
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rats, BDL rats showed significantly elevated serum concen-
trations of ALT, AST, ALK-P and total bilirubin, which is
consistent with hepatic inflammation and injury elicited by
BDL. The albumin level decreased from week 4 after BDL,
which also reflects the development of liver cirrhosis with
impaired albumin production.
With this model, we systematically revealed the whole
profile of hepatic and circulating cytokine changes, including
IFN-g, TNF-a, IL-10 and TGF-b during cirrhosis develop-
ment. The roles of cytokines facing hepatic damage are
complicated: they may be responsible for the establishment
and progression of hepatic injury, fibrosis and cirrhosis or
participate in liver regeneration.1 For instance, TNF-a, IL-6
and IL-1b are responsible for the activation of stellate cells,
which play pivotal roles in liver inflammation, fibrosis and
cirrhosis.1 In the current study, to our surprise, some of the
patterns of serum cytokine concentration changes were not
consistent with those of hepatic expression levels. This
suggests that the dynamic changes of hepatic cytokine
expression may not be merely reflected by the corresponding
serum levels.
After BDL, the hepatic IFN-g expression level elevated
progressively and reached a peak value in week 4. However,the serum concentration of IFN-gdid not change significantly
and was not correlated with its hepatic expression level.
Shindo et al had revealed that hepatic IFN-g mRNA correlated
with the severity of liver inflammation.17 Furthermore, hepatic
IFN-g expression was higher in patients with primary biliary
cirrhosis compared to patients with chronic hepatitis and
normal controls.7 Some authors describe a low but significant
increment in hepatic IFN-g mRNA, due to a fibrotic process
that is correlated with the degree of liver damage.18,19 The
earlier study noted that the plasma concentration of IFN-g was
increased in a patient with chronic liver disease, but such an
elevation is not different between cirrhotic and non-cirrhotic
patients.20 It seems that the serum concentration of IFN-g is
not a good indicator of liver cirrhosis.
The hepatic TNF-a expression was elevated and was
significantly higher in BDL rats than that in the corresponding
sham-operated rats. Although the serum TNF-a level
increased progressively, it did not reach a statistically signif-
icant difference as compared to the sham-operated rats.
Besides, the hepatic and circulatory TNF-a levels were not
significantly correlated. Tumor necrosis factor-a has been
associated with hepatic necrosis, because an elevated local or
systemic TNF-a induced focal hepatic necrosis1 and increased
serum levels of transaminases.21 Furthermore, hepatic necrosis
Fig. 5. (A) Kinetics of IL-10 expression in serum and liver tissue at 1, 2, 4, 6, 8 and 10 weeks after sham and BDL surgery. The data are expressed as mean SE
(n¼ 5 for each group). (B) Representative IHC staining patterns at different time points are shown. Magnification 100.
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hepatic TNF-a mRNA expression was increased in cirrhotic
patients.18 Regarding the circulating TNF-a, an elevated
plasma concentration of TNF-a reported in patients with
chronic liver disease which was significantly higher in
cirrhotics than in noncirrhotics.20 However, in Sprague-
Dawley rats, Plebani et al9 found a stable hepatic TNF-a
level throughout the 28 days following BDL. They argued that
synthesis and release of TNF-a in biliary cirrhosis appears to
be a continuous process that is caused by cholestasis, which
partially interferes with the normal metabolism of this cyto-
kine regulated by immunostimulation. Altogether, our data
suggest that in biliary cirrhosis, although synthesis of hepatic
TNF-a is augmented, the same statistical significance is not
found in the concentration of circulating TNF-a due to the
change of its release and metabolism.
Compared to the sham-operated group, the hepatic TGF-b
expression was enhanced significantly until 10 weeks after
BDL. Meanwhile, the serum TGF-b concentration showed
a positive correlation with the hepatic expression level and
was significantly higher at 6 and 8 weeks after BDL. Clini-
cally, the serum level of TGF-b reflects the severity of liver
damage in patients with primary biliary cirrhosis.23 Studies
with animals indicated that TGF-b1 is correlated with hepaticfibrosis and an enhanced hepatic expression of TGF-b1 has
been found in BDL rats.9 Consistent with the results reported
by Lee BS et al,11 the serum TGF-b level reached a peak in the
6th to 8th week in BDL rats. Our finding of hepatic TGF-b
expression is also partially in accord with that noted by
Plebani et al,9 showing that the hepatic TGF-b1 expression
was augmented fom the 14th to 28th day after BDL in rats.
The liver expression of IL-10 increased progressively after
BDL, reached a peak in week 4, and was significantly higher
than that of the corresponding sham-operated groups
throughout the time course. IL-10 can be synthesized by
several cell types in the liver in response to various stimuli.24
It is known as a cytokine synthesis inhibitory factor for T
lymphocytes25 with potent anti-inflammatory and anti-fibrotic
properties.26 In the study led by Fernandez-Martinez E et al,10
the amount of hepatic IL-10 was enhanced significantly after
BDL. Wang et al27 reported that in either in vitro or in vivo
condition, the hepatic stellate cells from Wistar rats underwent
BDL and showed high increments of IL-10 mRNA and protein
on the 7th day after BDL. However, this cytokine induction
disappeared in the advanced fibrotic stage (19th day after
BDL), indicating that the activation of hepatic stellate cells
induced an increased autocrine expression of IL-10 that
possessed negative regulatory effects on the production of
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Fig. 6. The correlation between corresponding hepatic expression and serum levels of IFN-g, TNF-a, TGF-b and IL-10 in all rats.
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found that the hepatic IL-10 expression remained high
throughout the 10 weeks following BDL, this may not be
contradictory because we evaluated the whole liver rather than
stellate cell IL-10 expression.
To our surprise, the serum IL-10 concentration was nega-
tively correlated with the hepatic IL-10 expression.Fig. 7. Plasma levels of ALT, AST, ALP-P, albumin and total bilirubin at 1, 2, 4
mean SE (n¼ 5 for each group).Furthermore, although not statistically significant, the serum
IL-10 concentration of BDL rats tended to be lower than that
of the sham-operated rats. The trend is compatible with the
finding that in patients with alcoholic cirrhosis, the serum level
of IL-10 was lower than that of healthy control subjects.28
Furthermore, compared with the healthy controls, patients
with compensated alcoholic cirrhosis were characterized by, 6, 8 and 10 weeks after sham and BDL surgery. The data are expressed as
393H.-G. Hsieh et al. / Journal of the Chinese Medical Association 74 (2011) 385e393a decreased serum IL-10 level, whereas the IL-10 level in
patients with decompensated alcoholic liver cirrhosis was
similar to that in controls.29 In another human study, most
cases of fibrosis in children were associated with low (< 47th
percentile) IL-10 factor scores.30 The underlying mechanism
remains obscure, but a recent study noted that 3 weeks
after BDL in rats, the liver contributed to the rapid plasma
disappearance of IL-10, probably due to an increase in
hepatic IL-10 receptor expression.31 An intriguing possibility
is that in cholestatic injury and fibrosis induced by BDL, the
counter-regulatory hepatic production of anti-inflammatory
and anti-fibrotic cytokine IL-10 was induced. Meanwhile,
the intrahepatic IL-10 receptor was up-regulated and the
serum IL-10 concentration decreased accordingly.
In conclusion, cirrhosis development in BDL rats is asso-
ciated with progressive enhancement of both pro-inflammatory
and anti-inflammatory cytokine expression in liver. However,
only parts of the changes of serum cytokine concentration are
consistent with those of hepatic expression, implying
a complex interplay of cytokine production, utilization and
metabolism in liver injury.Acknowledgments
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